Werds,
DB also said the H2 FY23 US formula sales has not been included yet. Hopefully, these sales( circa 1 million tins) and an improved US liquid milk performance reduces the US losses to a minimum. I recall FY22 was circa 30 million in losses.
My point here is that EBITDA margin would also improve with US formula sales hence my prediction of 14-15% margin.
The other variable is MVM which made a margin loss of 2.5% in FY22. Excluding MVM, EBITDA margins was 16.1% in FY22. We don’t know how this business will perform this year other than it will be insourcing more A2 business form Synlait( skim milk powder etc)
Ann: 2022 Annual Meeting, page-18
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.77 |
Change
0.130(1.96%) |
Mkt cap ! $4.894B | |||
| Open | High | Low | Value | Volume |
| $6.63 | $6.77 | $6.63 | $10.00M | 1.485M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2420 | $6.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.77 | 37726 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |